Innocan Pharma Corporation, a leader in the pharmaceutical and biotechnology sectors, is pleased to declare that it has received a patent in India for a prolonged-release pharmaceutical formulation that uses liposomes to encapsulate cannabinoids...
According to the World Health Organization (WHO), the global market for counterfeit drugs is valued at 200 billion USD, with 67% of these counterfeit drugs bring categorized as harmful to human health...
India's healthcare ecosystem is undergoing a remarkable transformation, driven by a growing focus on enhancing health services and fostering innovation. With rapid technological advancements and new medical breakthroughs, healthcare professionals...
The independent research organization BioMed X has finalized its oncology research initiative in collaboration with Merck, whose data has been obtained by Merck for additional development, possibly resulting in innovative therapeutic methods in...
In a webinar by ASSOCHAM on revolutionizing early cancer detection, Malti Sachdev, Head, Varian India shares her views on the relevance of taking cancer treatment in the early detection stages and the mindset to shift from fear to empowerment...
Dr. Reddy's Laboratories announced that its subsidiary has signed a licensing agreement with Shanghai Henlius Biotech, Inc. to develop and market a cancer drug currently in development. Dr Reddy's Laboratories SA has signed an agreement with the...
Algiax Pharmaceuticals, a biotech company in the clinical stage that specializes in creating innovative therapies for chronic neuropathic pain, revealed promising topline results from its phase 2a clinical trial assessing AP-325 for neuropathic...
Sigachi Industries Limited, a prominent entity in the pharmaceutical sector, is setting up a research and development center in Hyderabad, unifying its essential API Innovation and analytical initiatives in one location. This strategic plan...
Akums Drugs and Pharmaceuticals, a leader in contract development and manufacturing, has launched Dapagliflozin + Pioglitazone tablets; an advanced combination therapy designed to tackle the growing challenge of diabetes management...
Onco-Innovations Limited, a Canadian firm focused on cancer research and treatment, specializing in oncology, has shared details about its licensed technology involving a novel class of PNKP (Polynucleotide Kinase 3'-Phosphatase) inhibitors...
.jpg)
.jpg)
.jpg)
, CDSCO.jpg)